Antineoplastic agents | Tenderlake

Antineoplastic agents

Contract Value:
PLN 40M - 40M
Notice Type:
Contract award notice
Published Date:
05 January 2024
Closing Date:
Location(s):
PL613 Bydgosko-Toruński (PL Poland/POLSKA)
Description:
Procurement for the supply of various antineoplastic agents in accordance with specified regulations and pricing form.
Awarded to:
PEGFILGRASTIMUM
Asclepios S.A., Wrocław (PL)
DURVALUMABUM
AstraZeneca Kft., Budapeszt (HU)
APALUTAMIDUM
Janssen - Cilag Polska sp. z o.o., Warszawa (PL)
TRABECTEDINUM
Komtur Polska Sp. z o.o., Warszawa (PL)
RITUXIMABUM
Lek S.A., Stryków (PL)
PEGINTERFERONUM ALFA-2a
NEUCA S.A., Toruń (PL)
LENALIDOMIDUM
Salus International Sp. z o.o., Katowice (PL)
CEMIPLIMABUM
Sanofi-Aventis Sp. z o.o., Warszawa (PL)
RAMUCIRUMABUM
Urtica sp. z o.o., Wrocław (PL)
PACLITAXELUM ALBUMINATUM
Urtica Sp. z o.o., Wrocław (PL)
SACITUZUMABUM GOVITECANUM
Urtica Sp. z o.o., Wrocław (PL)
REGORAFENIBUM
Urtica Sp. z o.o., Wrocław (PL)
Download full details as .pdf
The Buyer:
Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy
CPV Code(s):
33652100 - Antineoplastic agents